Clinical and socioeconomic predictors of pregnancy termination for fetuses with congenital heart defects: A population-based evaluation

Prenatal Diagnosis

Volumn 33, Issue 2, 2013, Pages 179-186

  Tararbit, Karim ^a   Bui, Thi Thanh Thao ^a   Lelong, Nathalie ^a   Thieulin, Anne Claire ^a   Goffinet, François ^a,b   Khoshnood, Babak ^a  

^a INSERM   (France)

^b Université Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME ABERRATION; CONGENITAL HEART MALFORMATION; FETUS; FRANCE; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROBABILITY; SOCIOECONOMICS;

ABORTION, INDUCED; ADULT; FEMALE; GESTATIONAL AGE; HEART DEFECTS, CONGENITAL; HUMANS; LOGISTIC MODELS; PARIS; PREGNANCY; SOCIOECONOMIC FACTORS;

EID: 84873252200     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4043     Document Type: Article

References (33)

1. Dolk H, Loane M, Garne E. Congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011;123:841-9.
2. Khoshnood B, De Vigan C, Vodovar V, et al. Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, 1983-2000: a population-based evaluation. Pediatrics 2005;115:95-101.
3. Garne E, Loane M, Dolk H, et al. Prenatal diagnosis of severe structural congenital malformations in Europe. Ultrasound Obstet Gynecol 2005;25:6-11.
4. Garne E, Stoll C, Clementi M. Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol 2001;17:386-91.
5. Carvalho JS. Fetal heart scanning in the first trimester. Prenat Diagn 2004; 24:1060-7.
6. Simpson JM. Impact of fetal echocardiography. Ann Pediatr Cardiol 2009;2:41-50.
7. Carvalho JS, Moscoso G, Tekay A, et al. Clinical impact of first and early second trimester fetal echocardiography on high risk pregnancies. Heart 2004;90:921-6.
8. Botto LD, Correa A. Decreasing the burden of congenital anomalies/an epidemiologic evaluation of risk factors and survival. Progress in Pediatric Cardiology 2003;18:111-21.
9. Bonnet D, Coltri A, Butera G, et al. Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality. Circulation 1999;99:916-8.
10. Franklin O, Burch M, Manning N, et al. Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart 2002;87:67-9.
11. Allan LD, Cook A, Sullivan I, Sharland GK. Hypoplastic left heart syndrome: effects of fetal echocardiography on birth prevalence. Lancet 1991;337:959-61.
12. Allan LD, Huggon IC. Counselling following a diagnosis of congenital heart disease. Prenat Diagn 2004;24:1136-42.
13. Zyblewski SC, Hill EG, Shirali G, et al. Chromosomal anomalies influence parental treatment decisions in relation to prenatally diagnosed congenital heart disease. Pediatr Cardiol 2009;30:1105-11.
14. Tennstedt C, Chaoui R, Korner H, Dietel M. Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study. Heart 1999;82:34-9.
15. Garne E, Khoshnood B, Loane M, et al. Termination of pregnancy for fetal anomaly after 23weeks of gestation: a European register-based study. BJOG 2010;117:660-6.
16. Khoshnood B, Greenlees R, Loane M, Dolk H. Paper 2: EUROCAT public health indicators for congenital anomalies in Europe. Birth Defects Res A Clin Mol Teratol 2011;91(Suppl 1):S16-22.
17. Greenlees R, Neville A, Addor MC, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol 2011;91(Suppl 1):S51-100.
18. Cocchi G, Gualdi S, Bower C, et al. International trends of Down syndrome 1993-2004: births in relation to maternal age and terminations of pregnancies. Birth Defects Res A Clin Mol Teratol 2010;88:474-9.
19. Registre des Malformations de Paris. Surveillance épidémiologique et diagnostic prénatal des malformations: evolution sur vingt-sept ans (1981-2007). 2010. [WWW document].URL http://www.unites.inserm.fr/download.asp?download=stockfile/U149/documents/registre/brochure27ans.pdf [accessed on 22 August 2012].
20. Boyd PA, Devigan C, Khoshnood B, et al. Survey of prenatal screening policies in Europe for structural malformations and chromosome anomalies, and their impact on detection and termination rates for neural tube defects and Down's syndrome. BJOG 2008;115:689-96.
21. Garne E. The EUROCAT working group. Prenatal diagnosis of six major cardiac malformations in Europe-a population based study. Acta Obstet Gynecol Scand 2001;80:224-8.
22. Allan LD, Apfel HD, Printz BF. Outcome after prenatal diagnosis of the hypoplastic left heart syndrome. Heart 1998;79:371-3.
23. Galindo A, Nieto O, Villagra S, et al. Hypoplastic left heart syndrome diagnosed in fetal life: associated findings, pregnancy outcome and results of palliative surgery. Ultrasound Obstet Gynecol 2009;33:560-6.
24. Khoshnood B, De Vigan C, Vodovar V, et al. Advances in medical technology and creation of disparities: the case of Down syndrome. Am J Public Health 2006;96:2139-44.
25. Khoshnood B, Pryde P, Wall S, et al. Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome. Am J Public Health 2000;90:1778-81.
26. Kuppermann M, Gates E, Washington AE. Racial-ethnic differences in prenatal diagnostic test use and outcomes: preferences, socioeconomics, or patient knowledge? Obstet Gynecol 1996;87:675-82.
27. Smith LK, Budd JL, Field DJ, Draper ES. Socioeconomic inequalities in outcome of pregnancy and neonatal mortality associated with congenital anomalies: population based study. BMJ343:d4306.
28. Dommergues M, Benachi A, Benifla JL, et al. The reasons for termination of pregnancy in the third trimester. Br J Obstet Gynaecol 1999;106:297-303.
29. Marret H, Perrotin F, Descamps P, et al. Medical abortion in the second and third trimester. Report of 125 indications from 1992 to 1995. J Gynecol Obstet Biol Reprod (Paris). 1999;28:245-52.
30. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14weeks of gestation: population based cohort study. BMJ 1999;318:81-5.
31. Weiner Z, Weizman B, Beloosesky R, et al. Fetal cardiac scanning performed immediately following an abnormal nuchal translucency examination. Prenat Diagn 2008;28:934-8.
32. Botto LD, Lin AE, Riehle-Colarusso T, et al. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 2007;79:714-27.
33. Houyel L, Khoshnood B, Anderson RH, et al. Population-based evaluation of a suggested anatomic and clinical classification of congenital heart defects based on the International Paediatric and Congenital Cardiac Code. Orphanet J Rare Dis 2011;6:64.